Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 683,585 shares of the medical equipment provider's stock after selling 19,469 shares during the period. Intuitive Surgical comprises about 0.6% of DekaBank Deutsche Girozentrale's holdings, making the stock its 29th largest position. DekaBank Deutsche Girozentrale owned 0.19% of Intuitive Surgical worth $329,899,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Valeo Financial Advisors LLC increased its holdings in Intuitive Surgical by 1.4% in the first quarter. Valeo Financial Advisors LLC now owns 4,250 shares of the medical equipment provider's stock valued at $2,105,000 after buying an additional 57 shares in the last quarter. Liberty One Investment Management LLC raised its stake in Intuitive Surgical by 35.6% during the first quarter. Liberty One Investment Management LLC now owns 1,861 shares of the medical equipment provider's stock valued at $922,000 after buying an additional 489 shares in the last quarter. NTV Asset Management LLC acquired a new stake in Intuitive Surgical during the first quarter valued at approximately $236,000. Lee Johnson Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 4.9% in the 1st quarter. Lee Johnson Capital Management LLC now owns 8,740 shares of the medical equipment provider's stock worth $4,329,000 after purchasing an additional 411 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 12.0% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 11,026 shares of the medical equipment provider's stock valued at $5,461,000 after acquiring an additional 1,183 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG traded down $2.62 during midday trading on Tuesday, hitting $532.09. The stock had a trading volume of 199,013 shares, compared to its average volume of 1,665,273. The firm has a market cap of $190.71 billion, a PE ratio of 78.20, a price-to-earnings-growth ratio of 5.78 and a beta of 1.64. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock's 50 day moving average is $537.53 and its 200 day moving average is $536.99.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period last year, the firm posted $1.50 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president directly owned 5,224 shares in the company, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price objective for the company from $515.00 to $440.00 in a report on Monday, June 9th. Royal Bank Of Canada decreased their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Finally, Truist Financial decreased their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $592.59.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.